Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Inspira Technologies Oxy BHN ( (IINN) ) just unveiled an announcement.
On December 9, 2025, Inspira Technologies announced that it has been granted a patent in Japan for its Convertible Dual Lumen Cannula device, securing exclusive rights in a major medical device market until 2041. This patent complements their existing U.S. patent, enhancing their position in two of the largest healthcare economies. The innovative design of the cannula allows conversion from single to dual-lumen intravascularly, potentially reducing infection risks and procedural costs. This development solidifies Inspira’s foundation for respiratory support platforms and future disposable revenue streams.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company offers the INSPIRA ART100 system, approved for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S., and is developing the INSPIRA ART500 system. Additionally, it is advancing the HYLA blood sensor platform for continuous, non-invasive monitoring. With a growing IP portfolio and strategic operations, Inspira Technologies is positioned as a key player in the life-support and MedTech industry.
Average Trading Volume: 256,214
Technical Sentiment Signal: Sell
Current Market Cap: $31.8M
See more data about IINN stock on TipRanks’ Stock Analysis page.